drugset / Trial / NCT04392232
A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection
NaSingle-groupOpen-labelTreatment
Summary
Purpose of Study • The purpose of this study to evaluate, the effectiveness of convalescent plasma in combatting the symptoms and effects of the coronavirus disease, COVID-19. Beyond supportive care, there are no proven treatment options for COVID-19.
Timeline
- Start
- 2020-05-05
- Primary completion
- 2021-09-21
- Completion
- 2021-09-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Convalescent Plasma | Protein / enzyme biologic | — | — |